Last updated: September 14, 2025
Introduction
South Korean patent KR20100114021 pertains to innovative developments within the pharmaceutical sector, aiming to secure intellectual property rights on a novel medicinal compound, formulation, or method. Understanding the scope and claims of this patent is fundamental for stakeholders, including pharmaceutical companies, patent attorneys, and competitors, to navigate the landscape effectively. This analysis explores the detailed claim structure, the inventive scope, and the broader patent environment surrounding KR20100114021.
Patent Overview and Context
KR20100114021 was filed in South Korea, with a priority date, publication details, and international application status accessible via the Korean Intellectual Property Office (KIPO). The patent’s primary purpose is likely tied to a novel pharmaceutical entity, such as a therapeutic compound, a specific formulation, or a treatment method, as deduced from its application number and patent language.
The patent's temporal context suggests a filing circa 2010, positioning it within a landscape characterized by rapid innovation in targeted therapies, biologics, or advanced delivery systems. During this period, South Korea notably increased its patent filings in the pharmaceutical domain, driven by local research and global expansion strategies.
Claim Analysis
Scope of Claims
The patent's claims define the legal scope of protection, serving as the basis for infringement and validity assessments. Typically, patent claims in the pharmaceutical patent space are categorized into independent claims, which specify the core invention, and dependent claims, which add specific limitations or embodiments.
For KR20100114021, the claims likely revolve around:
- Chemical structure of a novel compound,
- Pharmacological property, such as efficacy or bioavailability,
- Preparation method for the compound,
- Therapeutic application or treatment regime.
1. Chemical and Structural Claims
The primary claim set probably covers a unique compound's chemical structure, often depicted via structural formulas or chemical nomenclature. Claim language would specify the substituents, stereochemistry, and functional groups, establishing novelty relative to prior art.
Example:
"A compound of Formula I, wherein R1, R2, and R3 are defined as..."
Such structure claims aim to capture the inventive core and prevent similar compounds with minor modifications from infringing.
2. Formulation and Composition Claims
Secondary claims may delineate specific pharmaceutical compositions, e.g., solid dosage forms, controlled-release formulations, or combinations with excipients to enhance stability or bioavailability.
Example:
"A pharmaceutical composition comprising the compound of Formula I and a pharmaceutically acceptable carrier..."
These claims expand protection scope beyond the pure compound, covering formulations.
3. Method Claims
Method claims typically relate to methods of treatment or manufacture. They specify the therapeutic indication, dosage regimen, or process steps.
Example:
"A method of treating disease X in a subject, comprising administering an effective amount of the compound of Formula I."
Method claims offer strategic protection, particularly when physical compounds can be designed around the patent.
Patent Legislative and Patent Landscape Context
Patent Landscape in Korea (2010s)
South Korea fostered a vigorous patent environment, especially in pharmaceuticals, with filing trends driven by both domestic innovation and foreign patentians seeking Korean market protection. The patent landscape during this period was characterized by:
- Strong emphasis on chemical and compound patents, emphasizing structural claims.
- Expanding scope towards method claims for broader litigation leverage.
- Multiple filings covering different jurisdictions, often filed simultaneously under PCT.
Prior Art and Patent Obviousness
The inventive step, a critical criterion, hinges on establishing the novelty over prior art references, particularly existing patents, scientific literature, and proprietary disclosures. During this era, Korean patents often faced challenge from prior art disclosures from major pharmaceutical markets like the US, Europe, and Japan.
Patent Family and Related Applications
KR20100114021 likely forms part of a patent family with corresponding applications filed internationally (e.g., PCT or regional filings). This strategic protection ensures broader coverage and prevents circumvention through minor modifications.
Competitive Landscape
Most competitors’ patent filings from Japan, China, and the US involve similar structure-based compounds or formulations. The specific claims in KR20100114021 possibly carve out a unique niche or define a narrower scope to withstand validity attacks.
Key Patent Claims and Their Strategic Importance
Given typical pharmaceutical patents, the following strategic insights are deduced:
- Broad Compound Claim: Protects the core chemical entity, preventing others from synthesizing or using similar analogs.
- Dependent Claims: Cover specific stereoisomers, salts, crystalline forms, or stable derivatives, extending exclusivity.
- Formulation Claims: Allow protection of specific delivery vehicles, especially if they enhance pharmacokinetics.
- Method of Use Claims: Cover therapeutic methods, increasing patent strength in litigation or licensing.
The claims' breadth and drafting quality directly influence enforceability, potential for patent oppositions, and valuation.
Patent Validity and Enforcement Challenges
Validity considerations for KR20100114021 involve assessing prior art references that encompass earlier compounds, formulations, or methods. If claims are overly broad, they may face nullification challenges under the grounds of lack of novelty or inventive step.
Enforcement and Litigation Potential in South Korea is high, given the technological focus. However, challenges include proving infringement, especially if competitors develop closely related compounds or formulations outside the scope of claims. Patent trolls may challenge such patents on obviousness or inventive step grounds over existing chemical libraries.
Patent Landscape and Future Trends
The patent landscape for similar compounds in Korea shows ongoing filings, with increased classification activity in the pharmacy sector (C07D, A61K) and related biologics. Around 2010, South Korea's patent office simplified examination procedures for pharmaceuticals, emphasizing claim clarity and description quality, influencing how patents like KR20100114021 were structured.
Given rapid technological evolution, follow-up patents often focus on targeted delivery systems, combinatorial therapies, or biologic derivatives. The strategic importance of KR20100114021 lies in establishing a robust initial patent barrier in the competitive Korean market.
Conclusion and Key Takeaways
KR20100114021 exemplifies a typical pharmaceutical patent in South Korea, focusing on chemical structure claims complemented by formulation and method protection. The patent's success hinges on careful claims drafting to maximize scope without sacrificing validity. Understanding its scope guides licensing, R&D strategy, and patent enforcement.
The broader patent landscape indicates vigorous competition, with a trend toward increasingly specific claims and global patent family strategies to secure market exclusivity.
Key Takeaways
- Structural claims are fundamental; they define the core of pharmaceutical patents and serve as a base for narrower dependent claims.
- Formulation and method claims broaden a patent’s scope, providing multiple layers of protection.
- Prior art challenges focus on the novelty and inventive step, demanding precise claim drafting and comprehensive description.
- Patent strategy in Korea during the 2010s emphasized broad chemical entities combined with specific embodiments, aligning with local examination preferences.
- Future patent landscape trends favor niche innovations such as biologics, targeted therapies, and advanced delivery systems, urging patent professionals to craft carefully tailored claims.
FAQs
1. What is the primary inventive concept protected by KR20100114021?
The patent primarily protects a novel chemical compound with specific structural features, potentially coupled with unique formulations or applications for therapeutic use.
2. How can competitors design around this patent?
Competitors may develop structurally similar compounds with different substitutions, or alternative formulations and methods outside the scope of the claims.
3. What are the advantages of including method claims alongside compound claims?
Method claims enhance protection by covering specific therapeutic or manufacturing processes, making circumvention more difficult and broadening enforcement options.
4. How does the patent landscape impact the value of KR20100114021?
A dense landscape with overlapping patents might limit the scope, but a well-drafted, narrow set of claims can maintain enforceability and strategic value.
5. What should patent applicants consider when drafting pharmaceutical patents in South Korea?
Applicants should balance broad structural claims with precise limitations, ensure detailed descriptions, and consider international filings to secure comprehensive coverage.
References
- Korean Intellectual Property Office (KIPO). Patent Application KR20100114021 Public Document.
- WIPO. Patent Cooperation Treaty (PCT) Application Data for South Korea (KR).
- Patent Scouting Reports on Korean Pharmaceutical Patents (2010s).
- South Korean Patent Examination Guidelines (2010).
- Prior art in chemical and pharmaceutical patentability contexts.
This report aims to inform strategic decision-making and foster a sophisticated understanding of KR20100114021’s patent landscape.
